Evaluating the appropriateness of granulocyte colony-stimulating factor (G-CSF) use in patients (pts) receiving myelosuppressive chemotherapy by febrile neutropenia (FN) risk level. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results